Pharma specialist Insight Research Group has appointed Gracie van Kemenade as Quantitative Research Director in the UK and Paul O’Meara as Regional Head of Syndicated Studies in the US.

Cello-owned Insight Research Group, which was established in 1983, specialises in providing market research to the healthcare sector. The company also operates in North America as Insight Health US.

In London, van Kemenade joins with more than 20 years’ experience covering continuous and ad-hoc research for the consumer and pharma sectors. Most recently, she served as a Director at Kantar Health (previously TNS Healthcare), where she was the global account lead for several pharma clients and managed a team of research execs.

In her new role, van Kemenade will focus on applying her experience to the development of new quant research methodologies, while also launching new tracking offerings which will initially target brand equity research.

O’Meara previously worked for Ipsos Healthcare in AsiaPac as Head of Syndicated Services and Oncology. He joins Insight’s New York office with 10 years’ experience of working in the healthcare market research sector.

Joint CEO Nicola Cowland comments: ‘Gracie and Paul’s recruitment is the latest step in bolstering Insight’s quantitative research capabilities, developing innovative and valuable new research offerings and affirming our presence as a leading global player in quantitative, qualitative and digital market research in the healthcare sector.’

Web site: www.insightrg.com .

• Printer-friendly version of this article.
• Email this article to a friend.